Condensed Consolidated Balance Sheet and Statement of Operations and Comprehensive Loss Components (Tables)

3 Months Ended

Mar. 31, 2026

Prepaid expenses and other current assets consist of the following:


	As of March 31, 2026		As of December 31, 2025

	(amounts in thousands)
Prepaid expenses	$	19,623	$	19,586
Other current assets	4,289		2,355
Total prepaid expenses and other current assets	$	23,912	$	21,941

Property and equipment, net consist of the following:


	As of March 31, 2026		As of December 31, 2025

	(amounts in thousands)
Computer equipment and software	$	80,570	$	76,430
Capitalized software	29,483		27,898
Laboratory equipment	124,312		106,227
Furniture and fixtures	8,410		8,368
Leasehold improvements/Leased buildings	64,215		63,812
Aircraft and leased equipment	21,415		21,415
Total property and equipment	328,405		304,150
Less: accumulated depreciation and amortization	(245,736)		(240,980)
Property and equipment, net	$	82,669	$	63,170

Accrued expenses and other current liabilities consist of the following:


	As of March 31, 2026		As of December 31, 2025

	(amounts in thousands)
Trade accruals	$	8,495	$	6,887
Accrued payroll and employee medical	15,394		11,104
Accrued bonus	8,556		31,487
Current portion of early exercise stock option liability	327		327
Contract liability	24,969		24,492
Current portion of operating lease liabilities	5,836		6,359

Other accrued expenses	10,344		7,114
Total accrued expenses and other current liabilities	$	73,921	$	87,770

Other long-term liabilities consist of the following:


	As of March 31, 2026		As of December 31, 2025

	(amounts in thousands)
Long-term operating lease liabilities, net of current portion	$	43,547	$	42,335
Long-term portion of early exercise stock option liability	53		53
Total other long-term liabilities	$	43,600	$	42,388

Caris Life Sciences, Inc. 10-Q